Home / Research Reports / Pharmaceuticals
Healthcare Foresights · Market Intelligence

Japan Brain Health Supplements Market 2026-2035

✓ Fact-checked research▣ Report code: HF1074◷ Published: March 21, 2026▤ 220+ pages⇩ PDF, Excel
▤220+ pages
▥12+ companies
▦Base year 2025
↗Forecast 2026–2035
◎Global coverage
819.4 MillionMarket size
3,316.4 MillionForecast value
16.8%CAGR
JapanCoverage
2025Base year

The Japan brain health supplements market is estimated at USD 705.2 million in 2025, rising to USD 819.4 million in 2026 and reaching about USD 3,316.4 million by 2035, at a 16.8% CAGR from 2026 to 2035. Growth is driven by the fast-aging population, rising attention to mental health, and preventive healthcare. Demand for memory, attention, mood and sleep supplements, plus innovation in natural molecules, herbal extracts and functional ingredients, supports expansion.

Japan Brain Health Supplements Market Size 2025 to 2035 (USD Million)

Market Highlights

  • Natural molecules and herbal extracts accounted for over 38.6% of 2025 revenue.
  • Tablets and capsules are projected to grow at a 17.2% CAGR from 2026 to 2035.
  • Memory enhancement held just under 33.5% of 2025 demand.
  • Pharmacies and drugstores supplied about 20% of 2025 revenue.

Significant Growth Factors

  • Product innovation and ingredient recognition, including a November 2024 award for Kyowa Hakko Bio's Cognizin citicoline.
  • Brain health showcases at Health Ingredients Japan 2025 highlighting preventive cognitive care.
  • Brand competition from Alpha-GPC, ginseng-based and established health companies.

Regulatory and Industry Developments

Food with Function Claims (FFC) allows companies to describe cognitive benefits, prompting firms such as FANCL and Meiji Holdings to align products with approved ingredients like DHA, ginkgo biloba and phosphatidylserine. The report also cites automated manufacturing, consolidation including Kirin's 2024 acquisition of FANCL, and local sourcing of key nutrients.

Category Insights

Natural molecules such as DHA/EPA, phosphatidylserine, amino acids and antioxidants are favored for clinical support. Herbal extracts like ginkgo biloba, bacopa and ashwagandha are growing fast. Tablets and capsules dominate for convenience and dosing accuracy; powders are growing quickly. Memory enhancement leads, supported by an aging population, while attention and focus is a high-growth segment. Pharmacies and drugstores dominate distribution due to consumer trust, while online retail is growing rapidly.

Report Scope

FeatureDetails
Market Size 2026USD 819.4 million
Projected Size 2035USD 3,316.4 million
Market Size 2025USD 705.2 million
CAGR16.8% (2026-2035)
Base Year2025

Major Developments

  • March 2025: FANCL launched a DHA and plant-based cognitive supplement.
  • July 2024: Otsuka released a next-generation DHA-based brain health product.
  • May 2025: Meiji Holdings set up a cognitive R&D center in Tokyo.
  • March 2025: Eisai presented an age-related memory soft gel.

Meet the team

This report was prepared by our expert analysts with deep industry knowledge and hands-on research experience.

Veena Jagtap

Author · Healthcare Research Manager

A results-driven Healthcare Research Manager at Custom Market Insights, specializing in healthcare market intelligence, industry analysis, competitive benchmarking, and strategic market assessments. Experienced in managing end-to-end healthcare research projects, analyzing industry trends, evaluating competitive landscapes, and identifying emerging market opportunities across pharmaceuticals, biotechnology, medical devices, healthcare services, and life sciences. Skilled in leading research initiatives, developing customized research methodologies, and transforming complex market data into actionable business insights. With a strong analytical mindset, strategic perspective, and commitment to research excellence, I focus on delivering accurate, data-driven intelligence that empowers clients to make informed business decisions, strengthen market positioning, and achieve sustainable growth in the evolving global healthcare industry.

Table of Contents

Explore the chapters covered in the full report.

Chapter 1. Report Introduction
  • 1.1 Report Description
    • 1.1.1 Purpose of the Report
    • 1.1.2 USP & Key Offerings
  • 1.2 Key Benefits For Stakeholders
  • 1.3 Target Audience
  • 1.4 Report Scope
Chapter 2. Market Overview
  • 2.1 Market Definition & Scope
  • 2.2 Key Market Takeaways
  • 2.3 Market Snapshot
Chapter 3. Market Dynamics (DRO)
  • 3.1 Drivers
  • 3.2 Restraints
  • 3.3 Opportunities
  • 3.4 Market Trends
Chapter 4. Japan Brain Health Supplements Market - By product type
  • 4.1 natural molecules and herbal extracts
  • 4.2 vitamins and minerals
Chapter 5. Japan Brain Health Supplements Market - By form
  • 5.1 tablets and capsules
  • 5.2 powders
  • 5.3 soft gels
Chapter 6. Japan Brain Health Supplements Market - By application
  • 6.1 memory enhancement
  • 6.2 attention and focus
  • 6.3 mood and stress management
  • 6.4 anti-aging and longevity
Chapter 7. Japan Brain Health Supplements Market - By distribution channel
  • 7.1 pharmacies and drugstores
  • 7.2 online retail
  • 7.3 supermarkets and hypermarkets
Chapter 8. Japan Brain Health Supplements Market - Regional Analysis
  • 8.1 North America
  • 8.2 Europe
  • 8.3 Asia Pacific
  • 8.4 Middle East & Africa
  • 8.5 Latin America
Chapter 9. Competitive Landscape
  • 9.1 Market Share Analysis
  • 9.2 Company Benchmarking
  • 9.3 Strategic Developments
Chapter 10. Company Profiles
  • 10.1 FANCL Corporation
  • 10.2 Otsuka Pharmaceutical Co. Ltd.
  • 10.3 Ajinomoto Co. Inc.
  • 10.4 Meiji Holdings Co. Ltd.
  • 10.5 Kyowa Hakko Bio Co. Ltd.
  • 10.6 Daiichi Sankyo Company Limited
  • 10.7 Eisai Co. Ltd.
  • 10.8 Takeda Pharmaceutical Company Limited
  • 10.9 Suntory Holdings Limited
  • 10.10 Yakult Honsha Co. Ltd.
  • 10.11 Nippon Shinyaku Co. Ltd.
  • 10.12 Kobayashi Pharmaceutical Co. Ltd.
Chapter 11. Research Methodology
  • 11.1 Research Approach
  • 11.2 Data Collection & Sources
  • 11.3 Market Estimation & Forecasting
  • 11.4 Data Validation & Triangulation
Chapter 12. Standard Report Commercials & Add-Ons
Chapter 13. List Of Figures
Chapter 14. List Of Tables

Company Listing

  • FANCL Corporation
  • Otsuka Pharmaceutical Co. Ltd.
  • Ajinomoto Co. Inc.
  • Meiji Holdings Co. Ltd.
  • Kyowa Hakko Bio Co. Ltd.
  • Daiichi Sankyo Company Limited
  • Eisai Co. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Suntory Holdings Limited
  • Yakult Honsha Co. Ltd.
  • Nippon Shinyaku Co. Ltd.
  • Kobayashi Pharmaceutical Co. Ltd.

Market Segments

Market Segmentation

By product type: natural molecules and herbal extracts, vitamins and minerals, others. By form: tablets and capsules, powders, soft gels. By application: memory enhancement, attention and focus, mood and stress management, anti-aging and longevity. By distribution channel: pharmacies and drugstores, online retail, supermarkets and hypermarkets.

Frequently asked questions

What drives market growth?
The aging population, growing attention to mental health, preventive healthcare, demand for natural and science-backed ingredients, and ongoing product innovation.
Which region leads?
The Kanto region, especially the Tokyo metropolitan area, with Kansai also showing strong growth potential.
What will the market size be by 2035?
About USD 3,316.4 million by the end of the forecast period, at a 16.8% CAGR.
What role do regulations play?
The Ministry of Health, Labour and Welfare oversees quality, safety and labeling, and the FOSHU and FFC frameworks add credibility and consumer trust.
Who are the key players?
FANCL, Otsuka, Ajinomoto, Meiji Holdings, Kyowa Hakko Bio, Daiichi Sankyo, Eisai, Takeda, Suntory, Yakult, Nippon Shinyaku and Kobayashi Pharmaceutical, among others.

Need a tailored view of this market?

Ask our analysts to adapt the scope for your priority geographies, competitive set, customer segments, or strategic questions.

Request Customisation → Request a Sample